AR014811A1 - Un peptido que enlaza anticuerpos con elevados niveles de pacientes esquizofrenicos, un ensayo para el diagnostico de la esquizofrenia y un equipopara el uso en el diagnostico de esquizofrenia - Google Patents
Un peptido que enlaza anticuerpos con elevados niveles de pacientes esquizofrenicos, un ensayo para el diagnostico de la esquizofrenia y un equipopara el uso en el diagnostico de esquizofreniaInfo
- Publication number
- AR014811A1 AR014811A1 ARP990101492A ARP990101492A AR014811A1 AR 014811 A1 AR014811 A1 AR 014811A1 AR P990101492 A ARP990101492 A AR P990101492A AR P990101492 A ARP990101492 A AR P990101492A AR 014811 A1 AR014811 A1 AR 014811A1
- Authority
- AR
- Argentina
- Prior art keywords
- diagnosis
- schizophrenia
- antibodies
- equipopara
- chichophrenia
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 201000000980 schizophrenia Diseases 0.000 title abstract 4
- 230000000698 schizophrenic effect Effects 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 210000001124 body fluid Anatomy 0.000 abstract 2
- 239000010839 body fluid Substances 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12392598 | 1998-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014811A1 true AR014811A1 (es) | 2001-03-28 |
Family
ID=11071395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101492A AR014811A1 (es) | 1998-04-02 | 1999-03-31 | Un peptido que enlaza anticuerpos con elevados niveles de pacientes esquizofrenicos, un ensayo para el diagnostico de la esquizofrenia y un equipopara el uso en el diagnostico de esquizofrenia |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7098304B1 (https=) |
| EP (1) | EP1068303B1 (https=) |
| JP (1) | JP4364433B2 (https=) |
| CN (1) | CN1171995C (https=) |
| AR (1) | AR014811A1 (https=) |
| AT (1) | ATE309335T1 (https=) |
| AU (1) | AU3165599A (https=) |
| BR (1) | BR9909308B1 (https=) |
| CA (1) | CA2324380C (https=) |
| DE (1) | DE69928236T2 (https=) |
| IL (1) | IL138746A (https=) |
| TW (1) | TW581812B (https=) |
| WO (1) | WO1999051725A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1331481A4 (en) * | 2000-10-31 | 2005-06-29 | Japan Government | KIT FOR THE DIAGNOSIS OF SCHIZOPHRENIA |
| EP1415162B1 (en) * | 2001-03-21 | 2011-05-11 | Yeda Research And Development Co., Ltd. | Novel peptides for the diagnosis of schizophrenia |
| CN1300588C (zh) * | 2005-02-28 | 2007-02-14 | 上海交通大学 | 用于精神分裂症诊断的血浆特异性蛋白获取方法及应用 |
| WO2007091881A2 (en) * | 2005-04-29 | 2007-08-16 | Leiden University Medical Center | Methods and means for detection of mycobacterium leprae infections |
| ES3038398T3 (en) * | 2015-07-14 | 2025-10-13 | Yeda Res & Dev | Peptide combinations for use in the diagnosis of schizophrenia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6913994A (en) | 1993-05-13 | 1994-12-12 | New York University | Psychosis protecting nucleic acid, peptides, compositions and method of use |
| US6008001A (en) * | 1993-11-05 | 1999-12-28 | Yeda Research And Development Co. Ltd. | Diagnosis of the susceptibility of contracting schizophrenia |
| AU695043B2 (en) | 1994-03-01 | 1998-08-06 | Yeda Research And Development Co. Ltd. | Assay for the diagnosis of schizophrenia |
-
1999
- 1999-03-30 EP EP99913557A patent/EP1068303B1/en not_active Expired - Lifetime
- 1999-03-30 AU AU31655/99A patent/AU3165599A/en not_active Abandoned
- 1999-03-30 CA CA002324380A patent/CA2324380C/en not_active Expired - Fee Related
- 1999-03-30 US US09/647,457 patent/US7098304B1/en not_active Expired - Lifetime
- 1999-03-30 WO PCT/IL1999/000190 patent/WO1999051725A2/en not_active Ceased
- 1999-03-30 DE DE69928236T patent/DE69928236T2/de not_active Expired - Lifetime
- 1999-03-30 CN CNB998059951A patent/CN1171995C/zh not_active Expired - Fee Related
- 1999-03-30 BR BRPI9909308-1A patent/BR9909308B1/pt not_active IP Right Cessation
- 1999-03-30 AT AT99913557T patent/ATE309335T1/de not_active IP Right Cessation
- 1999-03-30 JP JP2000542438A patent/JP4364433B2/ja not_active Expired - Lifetime
- 1999-03-31 TW TW088105128A patent/TW581812B/zh not_active IP Right Cessation
- 1999-03-31 AR ARP990101492A patent/AR014811A1/es not_active Application Discontinuation
-
2000
- 2000-09-28 IL IL138746A patent/IL138746A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2324380C (en) | 2009-02-24 |
| ATE309335T1 (de) | 2005-11-15 |
| BR9909308A (pt) | 2001-10-02 |
| HK1030966A1 (en) | 2001-05-25 |
| WO1999051725A2 (en) | 1999-10-14 |
| CN1300320A (zh) | 2001-06-20 |
| EP1068303A2 (en) | 2001-01-17 |
| DE69928236D1 (de) | 2005-12-15 |
| JP2002510712A (ja) | 2002-04-09 |
| WO1999051725A3 (en) | 1999-12-02 |
| AU3165599A (en) | 1999-10-25 |
| BR9909308B1 (pt) | 2010-11-30 |
| EP1068303B1 (en) | 2005-11-09 |
| JP4364433B2 (ja) | 2009-11-18 |
| IL138746A (en) | 2006-12-10 |
| US7098304B1 (en) | 2006-08-29 |
| CA2324380A1 (en) | 1999-10-14 |
| TW581812B (en) | 2004-04-01 |
| CN1171995C (zh) | 2004-10-20 |
| DE69928236T2 (de) | 2006-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Südhof et al. | Cassette of eight exons shared by genes for LDL receptor and EGF precursor | |
| ES2162917T3 (es) | Mejoras en o relativas al suministro de peptidos. | |
| DE69836630D1 (de) | Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren | |
| ES2173165T3 (es) | Metodo para obtener reactivos para diagnosticos, dosificados y terapias basado en la manifestaciones clinicas de una emfermedad. | |
| AR077568A2 (es) | Anticuerpos que ligan la interleucina -18 humana y metodos de preparacion y uso | |
| ES2123056T3 (es) | Anticuerpo bnp e inmunoensayo que lo emplea. | |
| ATE198754T1 (de) | Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung | |
| DE3855479D1 (de) | Hiv-peptide, künstliche hiv-antigene und immuntestsätze | |
| DE3679017D1 (de) | Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren. | |
| BR0314038A (pt) | Anticorpo humano isolado, método de tratar uma doença mediada com il-1 em um paciente, composição farmacêutica, cadeias pesada e leve, e, método de mapeamento de epitopo de um antìgeno selecionado | |
| AR047729A1 (es) | Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe) | |
| BR0113213A (pt) | Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo | |
| ATE106940T1 (de) | Für das polypeptid des t-zellantigenreceptors kodierende nukleinsäure. | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| DE69328726D1 (de) | Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen | |
| BR9106303A (pt) | Imonogeno humano composicao,celula de mamifero,peptido,vacina contra sintomas de esclerose multipla,metodo para tratar ou prevenir doenca com sintomas de esclerose multipla e conjunto para diagnosticar esclerose multipla | |
| ATE244299T1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
| ATE442439T1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
| AR014811A1 (es) | Un peptido que enlaza anticuerpos con elevados niveles de pacientes esquizofrenicos, un ensayo para el diagnostico de la esquizofrenia y un equipopara el uso en el diagnostico de esquizofrenia | |
| DE3884316D1 (de) | Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung. | |
| ATE164311T1 (de) | Orale, pharmazeutische zusammensetzungen das ein protein oder peptide, eine antikoerper und polymerkugeln enthalten | |
| ATE161543T1 (de) | Aminoterminale prokollagen 1(i) peptide | |
| ES2145061T3 (es) | Diagnostico y terapia a base de peptidos para el tratamiento de las espondiloartropatias. | |
| ES2308850T3 (es) | Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. | |
| AR013735A1 (es) | Inmunoensayo para el propeptido del procolageno iii c terminal, anticuerpos , propeptido del procolageno iii c terminal y uso de los anticuerpos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |